Clinical Trial
Smart water bottles and coaching increased hydration but did not cut kidney stone recurrences, trial finds
Сообщено ИИ Изображение, созданное ИИ Проверено фактами
In a two-year U.S. trial of 1,658 adolescents and adults with prior kidney stones, a technology-assisted hydration program modestly increased urine output but did not significantly reduce symptomatic stone recurrences compared with standard care.
A one-year course of the drug abatacept can delay the onset of rheumatoid arthritis by up to four years in high-risk individuals. The benefits persisted long after treatment stopped, according to new research from King's College London.
Сообщено ИИ
A minimally invasive procedure called duodenal mucosal resurfacing may help patients maintain weight loss after discontinuing drugs like Ozempic and tirzepatide. Early results from the REMAIN-1 clinical trial show treated participants regained far less weight than those in a control group after six months off medication. The findings are set for presentation at Digestive Disease Week 2026.
The Comandante Faustino Pérez Provincial Clinical Surgical Hospital has started a clinical trial using the Cuban drug Jusvinza to treat residual polyarthritis in chikungunya survivors. The study assesses the medication's ability to reduce ongoing pain and joint inflammation. It involves 120 patients and aims to provide an affordable treatment option.
Сообщено ИИ
In the Cuban province of Matanzas, a clinical trial has begun for the drug Jusvinza, developed by the Center for Genetic Engineering and Biotechnology (CIGB). The medication targets residual polyarthritis in patients recovering from chikungunya. This step represents progress in local healthcare efforts.
A Korean clinical trial has demonstrated that low-dose radiation therapy significantly reduces pain and improves mobility in patients with mild to moderate knee osteoarthritis, outperforming placebo effects. The treatment, which uses doses far below those for cancer, showed no side effects and could serve as an alternative to medications or surgery. Results were presented at the American Society for Radiation Oncology Annual Meeting.
Сообщено ИИ
A new topical serum containing plant extracts and growth proteins has shown promising results in increasing hair density and thickness within 56 days. Developed by researchers in Taiwan, the treatment outperformed a placebo in a small clinical trial involving 60 adults. While encouraging, experts call for larger studies to confirm its efficacy.